Investor Presentation
OUR STRATEGY
Growth Strategy
Highlights.
CONSUMER
House of Brands
Our highly curated brand portfolio currently
represents 85% of Flora's total revenue, and is
responsible for the rapid global expansion
realized by the company over the last 12
months. Consumer brands allow Flora to move
assertively into nascent markets, develop
customer bases and distribution channels and
gather consumer insights which would not be
possible with traditional cannabis sales.
Through this channel we build loyalty, credibility
and enjoy healthy margins that help to support
the rapid growth of the business.
O
2019 Present
COMMERCIAL
Cultivation and Transformation
With a unique cultivation facility and four
laboratories, Flora is able to meet the growing
and evolving needs of the global cannabis
trade.
With the cultivation of high-THC and high-CBD
flower, and the ability to transform the raw
goods into derivatives Flora has quickly built the
necessary infrastructure to support the export /
import of cannabis in key global markets as the
trade moves away from geo-fenced, regional
activities to international supply chain adoption.
O
2022
DEVELOPMENT
Life Sciences
Through the rigorous research and
development of plant-based medicines, Flora
seeks to upend how pharma-grade cannabis
products are brought to market.
The Life Sciences arm is actively developing
targeted medicines for markets around the
world, pursuing clinical trials, and bringing to
market products consumers and doctors can
trust.
2023
FLORA GROWTH
6View entire presentation